re: 4. prana's scientists on aust. abc tv science Prana’s...

re: 4. prana's scientists on aust. abc tv science Prana’s scientists on Australian ABC TV science program,
Catalyst Thursday, 17 June, 2004:

Prana Biotechnology (ASX:PBT, NASDAQ:PRAN) is pleased to announce that an interview with Professor Ashley Bush and Dr Robert Cherny about Prana’s technology for treating Alzheimer’s disease will be featured on Australian (ABC) television science program, Catalyst, tonight Thursday June 17 at 8pm.

Professor Bush is the Chief Scientific Consultant to Prana Biotechnology and a coinventor of the company’s MPAC technology which has shown significant promise in
early trials as a treatment for Alzheimer’s disease.

Professor Bush is the Director of the Laboratory for Oxidation Biology, within the Genetics and Aging Unit and Associate Professor in the Department of Psychiatry of Harvard Medical School at the
Massachusetts General Hospital.

He is also Principal Fellow/Associate Professor,
Departments of Pathology and Psychiatry, University of Melbourne. Dr Robert Cherny is a Senior Scientist for Prana and a Senior Research Officer at the Department of Pathology University of Melbourne at the Mental Health Research Institute.

Catalyst is a weekly television program on Australian Broadcasting Corporation which provides a mixture of local and international scientific stories investigating the
breakthroughs, ethics and the politics of science.

About Prana’s technology:
PBT-1 and PBT-2 are Metal Protein Attenuating Compounds or MPACs. Prana’s MPACs are chemicals that
bind zinc and copper, and have been shown to lower the levels of amyloid beta (and associated toxicity) in
the brains of transgenic mice used as a model of Alzheimer’s Disease.

About Prana
Prana is a Melbourne-based biotechnology established in 1997 to commercialize research into Alzheimer's
disease and other major age-related degenerative disorders (Nasdaq: PRAN; ASX: PBT).

Prana's technology was discovered by the company's researchers at prominent international institutions includingMassachusetts General Hospital at Harvard Medical School, the University of Melbourne and the Mental Health Research Institute in Melbourne. For more information about Prana, please visit www.pranabio.com

For more information contact:
Company Media and Investor, US Media, Australia
Geoffrey Kempler, Prana Ivette Almeida and Steven Silver Kate Mazoudier
+61 (3) 9690 7892 212-983-1702 ext. 209 and 212 +61 3 9866 4722
[email protected] [email protected]
[email protected]